Susannah J. Brock
Bournemouth, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study.
Journal: Nature cancer
Published: July 18, 2025
A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial Carcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 12, 2022
Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: December 21, 2021
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Journal: International journal of cancer
Published: December 10, 2021
Measuring the working experience of doctors in training.
Journal: Future healthcare journal
Published: October 23, 2020
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness.
Journal: European urology oncology
Published: April 11, 2018
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 13, 2018
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Journal: The New England journal of medicine
Published: June 06, 2017
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
Journal: Lancet (London, England)
Published: January 01, 2016
Levobupivacaine for low-dose spinal anaesthesia.
Journal: British journal of anaesthesia
Published: January 17, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026